Taiwan-based United Biomedical Inc. (UBI) Asia on Monday said it will file an appeal with the Taiwan Food and Drug Administration (FDA) after its request for emergency use authorization (EUA) for its COVID-19 vaccine was denied.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
CPC keeps residential, industrial gas prices steady; utility rates to drop
06/30/2026 08:32 PM - Society
Taiwan's new workplace bullying rules: What to know
06/30/2026 08:31 PM - Society
Taiwan to add rotavirus vaccine to free immunization program in 2027
06/30/2026 08:13 PM - Business
Taiwan's 2025 domestic production of export orders hits record 52.9%
06/30/2026 07:50 PM - Society
Taipei Metro to accept credit cards and mobile pay starting July 1
06/30/2026 06:20 PM